This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03319/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03319/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03319/identifier/pubchem-substance/
n12http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03319/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03319
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03319 n12:DB03319
dcterms:title
(S)-ATPA
adms:identifier
n8:46936640 n9:46506972 n10:DB03319 n11:CE2
n3:synonym
(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid
n3:IUPAC-Name
n4:271B6458-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B645E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B645D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B645A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B645B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B645C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6456-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6454-363D-11E5-9242-09173F13E4C5 n4:271B6457-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6455-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6464-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6465-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B645F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6460-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6462-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6461-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6463-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B646A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B646C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B646D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6469-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6468-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B646B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6459-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6466-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6467-363D-11E5-9242-09173F13E4C5